Biswas, S., Srivastava, Y., Falodia, R., Hamadttu, A. (2026). Fruquintinib versus trifluridine-tipiracil plus bevacizumab versus regorafenib in refractory metastatic colorectal cancer: A propensity score–matched real-world analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.134